Kinetic characterization of human JNK2alpha2 reaction mechanism using substrate competitive inhibitors. 2007

Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
Department of Biochemical Pharmacology, Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, USA.

Jun N-terminal kinase (JNK) is a stress activated serine/threonine protein kinase that phosphorylates numerous cellular protein substrates including the transcription factors c-Jun and ATF2. In this study, we defined the kinetic mechanism for the active form of JNK2alpha2. Double reciprocal plots of initial rates versus concentrations of substrate revealed the sequential nature of the JNK2alpha2 catalyzed ATF2 phosphorylation. Dead-end JNK inhibitors were then used to differentiate ordered and random kinetic mechanisms for the reaction. A peptide inhibitor containing the homology JNK docking sequence for substrate recognition, derived from amino acid residues 153-163 of JNK-interacting protein 1 (JIP-1), inhibited JNK activity via competition with ATF2. This peptide functioned as a noncompetitive inhibitor against ATP. In contrast, the anthrapyrazolone compound, SP600125, exhibited competitive inhibition for ATP and noncompetitive inhibition against ATF2. Furthermore, binding of one substrate had no significant effect on the affinity for the other substrate. The data in this study are consistent with a kinetic mechanism for activated JNK2alpha2 in which (1) substrate binding is primarily due to the distal contacts in the JNK2alpha2 docking groove that allow the delivery of the substrate phosphorylation sequence into the catalytic center, (2) there is minimal allosteric communication between the protein-substrate docking site and the ATP binding site in the catalytic center for activated JNK2alpha2, and (3) the reaction proceeds via a random sequential mechanism.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D048056 Mitogen-Activated Protein Kinase 9 A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 48 and 54 KD exist due to multiple ALTERNATIVE SPLICING. JNK2 Kinase,JNK2 Stress-Activated Protein Kinase,MAPK9 Mitogen-Activated Protein Kinase,Stress-Activated Protein Kinase JNK2,c-jun Kinase-2,c-jun N-terminal Kinase 2,JNK2 Stress Activated Protein Kinase,Kinase-2, c-jun,MAPK9 Mitogen Activated Protein Kinase,Mitogen Activated Protein Kinase 9,Stress Activated Protein Kinase JNK2,c jun Kinase 2,c jun N terminal Kinase 2
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins

Related Publications

Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
April 1975, Zeitschrift fur klinische Chemie und klinische Biochemie,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
October 1973, Biochemical and biophysical research communications,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
October 2015, IUBMB life,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
May 1975, Zeitschrift fur klinische Chemie und klinische Biochemie,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
December 1980, Biochemical medicine,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
November 1980, Archives of biochemistry and biophysics,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
March 2000, European journal of biochemistry,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
September 2017, The FEBS journal,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
December 1984, Biochemistry international,
Linghao Niu, and Kung-Ching Chang, and Stacy Wilson, and Patricia Tran, and Fengrong Zuo, and David C Swinney
December 2001, Analytical chemistry,
Copied contents to your clipboard!